Pencil Beam Scanning

RADIATION2 trials

Sponsors

Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)

Conditions

Astrocytoma, IDH-Mutant, Grade 3Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma

Phase 2

Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma

Not yet recruitingNCT07572123

National Cancer Institute (NCI)Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma

Start: 2026-12-04End: 2029-03-31Target: 374Updated: 2026-07-08

Phase 3

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

RecruitingNCT07215910

Alliance for Clinical Trials in OncologyAstrocytoma, IDH-Mutant, Grade 3

Start: 2026-07-20End: 2040-01-01Target: 408Updated: 2026-07-02

Related Papers

Alliance A072301: A phase III trial of radiotherapy followed by adjuvant temozolomide in combination with vorasidenib vs placebo in <i>IDH</i> -mutated newly diagnosed grade 3 astrocytoma (VORTEX).

Journal of Clinical Oncology2026-05-28